1d agoThe Motley FoolBULLISH 63Earnings
Cellebrite (CLBT) Q3 2026 Earnings Call Transcript
New AI product debuted strongly while a U.S. redomicile move advances.
Archived explainer. For the current picture see today's CLBT page.
Why Is CELLEBRITE DI LTD A (CLBT) Stock Up Today?
By the Top Tier Newswire AI Desk · November 13, 2026 at 9:50 AM ET · reviewed against 8 wire stories
CELLEBRITE DI LTD A (CLBT) is up +7.25% in the latest session. Our newswire has captured 8 stories on CLBT across 5 sources in the last 36 hours, with AI sentiment reading mixed (avg 54/100).
Public view, delayed 4h. Every headline, price and sentiment read below — and this write-up itself — reaches Pro subscribers live. Public readers see it once it clears the delay.
Cellebrite DI Ltd (CLBT) shares rose 7.25% to $11.68 following the release of third-quarter 2026 financial results. The primary driver was a beat on revenue and earnings estimates, accompanied by a reaffirmation of annual recurring revenue targets.
What Happened
The company reported Q3 revenue of $149.02 million, exceeding estimates by $3.13 million and rising 18.2% year over year. GAAP EPS of $0.10 beat the consensus by $0.02, while adjusted EPS of $0.17 surpassed the $0.16 estimate. Management reaffirmed its target for annual recurring revenue (ARR) of $550 million to $560 million, with Q3 ARR growing 20% to $528.5 million. Despite the strong top-line performance, Cellebrite slightly lowered its full-year 2026 revenue guidance to $553 million to $558 million from the previous range of $555 million to $561 million. The company also raised its full-year adjusted EBITDA outlook to $163 million to $166 million. Q3 net income was $26.7 million, and adjusted EBITDA reached $53.6 million, representing a 36% margin.
What The Data Shows
The stock opened at $11.20, a 2.8% gap up from the prior close of $10.89. It touched a session high of $11.70 at 9:50 AM ET and a low of $10.88 at 9:30 AM ET. Volume stood at 0.5 million shares, which is 0.2 times the three-month daily average. Fundamentals show a market cap of $3.2 billion and a P/E ratio of 47.4. The 52-week range is $9.58 to $19.98. Over the last 8 sessions, the stock had declined 3.2% from $11.23 to $10.86. Recent insider activity includes six sales totaling $642,000 in the last 90 days, with no buys. The most recent sale was by Global Chief Revenue Officer Jewell Marcus on November 12, 2026.
What To Watch
Investors will monitor the company's progress toward its $550 million to $560 million ARR target and the execution of its U.S. redomicile move. The next scheduled earnings report is not specified in the current data, but coverage breadth remains high with eight stories from five sources in the last 36 hours.
AI-assisted analysis composed exclusively from headlines and data on the Top Tier newswire. Public view is delayed 4 hours from real time. Not financial advice.
CLBT by the numbers
Last: $11.68Session: +7.25%7 sessions: -3.21%Coverage: 8 stories / 5 sourcesAI sentiment: 54/100 (mixed)Mkt cap: $3.2BP/E: 47.452w: $9.58 to $19.98
The headlines behind the move
1d agoSeeking AlphaBULLISH 74Earnings
Cellebrite projects $163M-$166M adjusted EBITDA in 2026 as it reaffirms $550M-$560M ARR
Cellebrite tops Q3 guidance as ARR grows 20% to $528.5 million and raises full-year adjusted EBITDA outlook to $163-$166 million.
1d agoSeeking AlphaNEUTRAL 50Earnings
Cellebrite DI Ltd. (CLBT) Q3 2026 Earnings Call Transcript
Cellebrite DI Ltd. (CLBT) Q3 2026 Earnings Call November 12, 2026 8:30 AM ESTCompany ParticipantsAndrew Kramer - VP of Investor Relations &...
1d agoThe FlyBEARISH 38Earnings
Cellebrite cuts FY26 revenue view to $553M-$558M from $555M-$561M
1d agoBusiness InsiderBULLISH 64Earnings
Cellebrite GAAP EPS of $0.10 beats by $0.02, revenue of $149.02M beats by $3.13M
Cellebrite Q3 earnings: revenue rises 18.2% year over year to $149.02 million, beating estimates by $3.13 million; GAAP EPS of $0.10 beats by $0.02.
1d agoThe FlyBEARISH 38Earnings
Cellebrite sees Q4 revenue $145M-$150M, consensus $151.44M
1d agoThe FlyBULLISH 56Earnings
Cellebrite Reports Q3 Adjusted Eps 17c Consensus 16c
1d agoStockTitanNEUTRAL 50Earnings
Cellebrite Reports Third-Quarter 2026 Results
Third-Quarter ARR Growth of 20% and TTM Free Cash Flow Margin of 31% Net income of $26.7 million; Non-GAAP net income of $45.6 million and adjusted EBITDA of $53.6 million, 36% adjusted EBITDA margin TYSONS CORNER, Va. and PETAH TIKVA, Israel, Nov. 12, 2026 /PRNewswire/ -- Cellebrite DI...
Want the next move before the crowd? The live terminal streams every headline in real time with watchlist alerts, AI sentiment, and the full data stack behind this page.Get Pro Access →
More on CLBT: full news and sentiment history. Sentiment scores are AI-derived research signals, not financial advice.
Earlier CLBT move explainers: 2026-11-13 · 2026-11-12 · 2026-08-24 · 2026-08-18 · 2026-08-17 · 2026-08-13